AMGN vs HUM
By Alex · Tickerpine
Amgen Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | HUM |
|---|---|---|
| Price | $416.18 | $388.83 |
| Market cap | $225.15B | $46.69B |
| P/E ratio | 25.7 | 35.2 |
| ROE | 91.47% | 6.89% |
| Profit margin | 22.95% | 0.88% |
| Revenue growth | 9.50% | 26.20% |
| Dividend yield | 2.43% | 0.95% |
| Beta | 0.41 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs HUM in plain English
- AMGN is the bigger company — about 4.8× the market cap of HUM.
- AMGN is cheaper on earnings (P/E 25.7 vs 35.2).
- AMGN earns a higher return on equity (91% vs 7%).
- HUM is growing revenue faster (26% vs 10%).
- AMGN has the higher dividend yield (2.43% vs 0.95%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.